- Report
- March 2025
- 196 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- June 2022
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- November 2021
- 180 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- October 2023
- 145 Pages
Global
From €2995EUR$3,150USD£2,516GBP
Photobiomodulation (PBM) is a medical device technology that uses light to stimulate and modulate biological processes. It is used to treat a variety of conditions, including pain, inflammation, wound healing, and neurological disorders. PBM devices use light of specific wavelengths and intensities to target specific cells and tissues, and can be used to treat both acute and chronic conditions.
PBM devices are used in a variety of medical settings, including hospitals, clinics, and home care. They are also used in veterinary medicine, sports medicine, and physical therapy. PBM devices are typically non-invasive and have few side effects, making them an attractive option for many patients.
The PBM market is growing rapidly, driven by increasing demand for non-invasive treatments and the development of new technologies. Companies in the PBM market include Photomedex, Inc., LiteCure, LLC, and Biolitec AG. Show Less Read more